Differential gene expression profiles of neurothekeomas and nerve sheath myxomas by microarray analysis

Modern Pathology

Volumn 24, Issue 3, 2011, Pages 343-354

  Sheth, Sachiv ^a   Li, Xinmin ^a   Binder, Scott ^a   Dry, Sarah M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

cellular fibrous histiocytoma; formalin fixed paraffin embedded; gene expression microarray; nerve sheath myxoma; neurothekeoma; schwannoma

Indexed keywords

FORMALDEHYDE; PARAFFIN;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DERMATOFIBROMA; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MICROARRAY ANALYSIS; MIXED TUMOR; MYXOMA; NEURILEMOMA; NEUROTHEKEOMA; PRIORITY JOURNAL; RNA ISOLATION; SKIN TUMOR;

ADOLESCENT; ADULT; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTIOCYTOMA, MALIGNANT FIBROUS; HUMANS; MALE; MICROARRAY ANALYSIS; NEURILEMMOMA; NEUROTHEKEOMA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PERIPHERAL NERVOUS SYSTEM NEOPLASMS; SKIN; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 79952188813     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2010.203     Document Type: Article

References (90)

1. Gallager RL, Helwig EB. Neurothekeoma-a benign cutaneous tumor of neural origin. Am J Clin Pathol 1980;74:759-764. (Pubitemid 11212909)
2. Pulitzer DR, Reed RJ. Nerve-sheath myxoma (perineur-ial myxoma). Am J Dermatopathol 1985;7:409-421.
3. Allen PW. Myxoma is not a single entity: a review of the concept of myxoma. Ann Diagn Pathol 2000;4: 99-123.
4. Argenyi ZB, Balogh K, Abraham AA. Degenerative ('ancient') changes in benign cutaneous schwannoma. A light microscopic, histochemical and immunohisto-chemical study. J Cutan Pathol 1993;20:148-153. (Pubitemid 23215565)
5. Barnhill RL, Mihm Jr MC. Cellular neurothekeoma A distinctive variant of neurothekeoma mimicking nevomelanocytic tumors. Am J Surg Pathol 1990;14: 113-120. (Pubitemid 20039006)
6. Barnhill RL, Dickersin GR, Nickeleit V, et al. Studies on the cellular origin of neurothekeoma: clinical, light microscopic, immunohistochemical, and ultrastructur-al observations. J Am Acad Dermatol 1991;25:80-88.
7. Hollowood K, Holley MP, Fletcher CD. Plexiform fibrohistiocytic tumour: clinicopathological, immuno-histochemical and ultrastructural analysis in favour of a myofibroblastic lesion. Histopathology 1991;19: 503-513.
8. Bhaskar AR, Kanvinde R. Neurothekeoma of the hand. J Hand Surg Br 1999;24:631-633. (Pubitemid 29520885)
9. Fullen DR, Lowe L, Su LD. Antibody to S100a6 protein is a sensitive immunohistochemical marker for neu-rothekeoma. J Cutan Pathol 2003;30:118-122. (Pubitemid 36384856)
10. Husain S, Silvers DN, Halperin AJ, et al. Histologic spectrum of neurothekeoma and the value of immu-noperoxidase staining for S-100 protein in distinguishing it from melanoma. Am J Dermatopathol 1994;16: 496-503. (Pubitemid 24323356)
11. Rosati LA, Fratamico FC, Eusebi V. Cellular neurothe-keoma. Appl Pathol 1986;4:186-191.
12. Connolly M, Hickey JR, Intzedy L, et al. Subungual neurothekeoma. J Am Acad Dermatol 2005;52: 159-162. (Pubitemid 40038959)
13. Harkin JC, Reed RJ. Tumors of the peripheral nervous system. In: Rosai J (ed). Atlas of Tumor Pathology Vol. 2nd series Fascicle 3, Armed Forces Institute of Pathology: Washington DC, 1969, pp 29-65.
14. Vougioukas VI, Roeske S, Michel U, et al. Wallerian degeneration in ICAM-1-deficient mice. Am J Pathol 1998;152:241-249. (Pubitemid 28028064)
15. Yamate J, Yasui H, Benn SJ, et al. Characterization of newly established tumor lines from a spontaneous malignant schwannoma in F344 rats: nerve growth factor production, growth inhibition by transforming growth factor-beta1, and macrophage-like phenotype expression. Acta Neuropathol 2003;106:221-233. (Pubitemid 37021254)
16. Misago N, Satoh T, Narisawa Y. Cellular neurothekeo-ma with histiocytic differentiation. J Cutan Pathol 2004;31:568-572.
17. Griffin JW, George R, Ho T. Macrophage systems in peripheral nerves. A review. J Neuropathol Exp Neurol 1993;52:553-560. (Pubitemid 23335730)
18. Angervall L, Kindblom LG, Haglid K. Dermal nerve sheath myxoma. A light and electron microscopic, histochemical and immunohistochemical study. Cancer 1984;53:1752-1759. (Pubitemid 14127518)
19. Blumberg AK, Kay S, Adelaar RS. Nerve sheath myxoma of digital nerve. Cancer 1989;63:1215-1218. (Pubitemid 19074757)
20. Wang AR, May D, Bourne P, et al. PGP9.5: a marker for cellular neurothekeoma. Am J Surg Pathol 1999;23: 1401-1407. (Pubitemid 29517334)
21. Laskin WB, Fetsch JF, Miettinen M. The 'neurothekeo-ma': immunohistochemical analysis distinguishes the true nerve sheath myxoma from its mimics. Hum Pathol 2000;31:1230-1241.
22. Scheithauer B, Woodruff J, Erlandson R. Miscellaneous benign neurogenic tumors. In: Rosai J, Sobin L (eds). Atlas of Tumor Pathology Tumors of the Peripheral Nervous System, 3rd series Armed Forces Institute of Pathology: Washington DC, 1999, pp 219-282.
23. Zelger BG, Steiner H, Kutzner H, et al. Cellular 'neurothekeoma': an epithelioid variant of dermatofi-broma? Histopathology 1998;32:414-422. (Pubitemid 28231374)
24. Salomao DR, Nascimento AG. Plexiform fibrohistiocy-tic tumor with systemic metastases: a case report. Am J Surg Pathol 1997;21:469-476. (Pubitemid 27184781)
25. Requena L, Sangueza OP. Benign neoplasms with neural differentiation: a review. Am J Dermatopathol 1995;17:75-96.
26. Paulus W, Jellinger K, Perneczky G. Intraspinal neurothekeoma (nerve sheath myxoma). A report of two cases. Am J Clin Pathol 1991;95:511-516.
27. Fetsch JF, Laskin WB, Hallman JR, et al. Neuro-thekeoma: an analysis of 178 tumors with detailed immunohistochemical data and long-term patient follow-up information. Am J Surg Pathol 2007;31: 1103-1114. (Pubitemid 47012308)
28. Fetsch JF, Laskin WB, Miettinen M. Nerve sheath myxoma: a clinicopathologic and immunohistochem-ical analysis of 57 morphologically distinctive, S-100 protein- and GFAP-positive, myxoid peripheral nerve sheath tumors with a predilection for the extremities and a high local recurrence rate. Am J Surg Pathol 2005;29:1615-1624.
29. Hornick JL, Fletcher CD. Cellular neurothekeoma: detailed characterization in a series of 133 cases. Am J Surg Pathol 2007;31:329-340. (Pubitemid 46673106)
30. Fedorowicz G, Guerrero S, Wu TD, et al. Microarray analysis of RNA extracted from formalin-fixed, paraffin-embedded and matched fresh-frozen ovarian ade-nocarcinomas. BMC Med Genomics 2009;2:23.
31. Koh SS, Opel ML, Wei JP, et al. Molecular classification of melanomas and nevi using gene expression microarray signatures and formalin-fixed and paraffin-embedded tissue. Mod Pathol 2009;22:538-546.
32. Ravo M, Mutarelli M, Ferraro L, et al. Quantitative expression profiling of highly degraded RNA from formalin-fixed, paraffin-embedded breast tumor biopsies by oligonucleotide microarrays. Lab Invest 2008; 88:430-440. (Pubitemid 351432771)
33. Linton KM, Hey Y, Saunders E, et al. Acquisition of biologically relevant gene expression data by Affymetrix microarray analysis of archival formalin-fixed paraffin-embedded tumours. Br J Cancer 2008;98:1403-1414. (Pubitemid 351543581)
34. Paik S, Kim CY, Song YK, et al. Technology insight: application of molecular techniques to formalin-fixed paraffin-embedded tissues from breast cancer. Nat Clin Pract Oncol 2005;2:246-254. (Pubitemid 40812455)
35. LeBoit PE, Burg G, Weedon D, et al. Pathology and Genetics of Skin Tumours. IARC Press: Lyon, 2006.
36. Calonje E, Mentzel T, Fletcher CD. Cellular benign fibrous histiocytoma. Clinicopathologic analysis of 74 cases of a distinctive variant of cutaneous fibrous histiocytoma with frequent recurrence. Am J Surg Pathol 1994;18:668-676. (Pubitemid 24187527)
37. Scotto C, Deloulme JC, Rousseau D, et al. Calcium and S100B regulation of p53-dependent cell growth arrest and apoptosis. Mol Cell Biol 1998;18:4272-4281. (Pubitemid 28287950)
38. Cheng Y, Cheung M, Abu-Elmagd MM, et al. Chick sox10, a transcription factor expressed in both early neural crest cells and central nervous system. Brain Res Dev Brain Res 2000;121:233-241. (Pubitemid 30392448)
39. Giese KP, Martini R, Lemke G, et al. Mouse P0 gene disruption leads to hypomyelination, abnormal expression of recognition molecules, and degeneration of myelin and axons. Cell 1992;71:565-576.
40. Schaich M, Budzinski RM, Stoffel W. Cloned proteo-lipid protein and myelin basic protein cDNA transcription of the two genes during myelination. Biol Chem Hoppe Seyler 1986;367:825-834.
41. Mandai K, Nakanishi H, Satoh A, et al. Ponsin/ SH3P12: an l-afadin- and vinculin-binding protein localized at cell-cell and cell-matrix adherens junctions. J Cell Biol 1999;144:1001-1017. (Pubitemid 29238974)
42. Vits L, Van Camp G, Coucke P, et al. MASA syndrome is due to mutations in the neural cell adhesion gene L1CAM. Nat Genet 1994;7:408-413. (Pubitemid 24204418)
43. Harroch S, Furtado GC, Brueck W, et al. A critical role for the protein tyrosine phosphatase receptor type Z in functional recovery from demyelinating lesions. Nat Genet 2002;32:411-414. (Pubitemid 35266117)
44. Wakamatsu Y, Endo Y, Osumi N, et al. Multiple roles of Sox2, an HMG-box transcription factor in avian neural crest development. Dev Dyn 2004;229:74-86. (Pubitemid 38036823)
45. Narayanan V, Ripepi B, Jabs EW, et al. Partial structure and mapping of the human myelin P2 protein gene. J Neurochem 1994;63:2010-2013. (Pubitemid 24369972)
46. Miyoshi K, Honda A, Baba K, et al. Disrupted-in-schizophrenia 1, a candidate gene for schizophrenia, participates in neurite outgrowth. Mol Psychiatry 2003;8:685-694. (Pubitemid 36976300)
47. Lodge AP, McNamee CJ, Howard MR, et al. Identification and characterization of CEPU-Se-A secreted isoform of the IgLON family protein, CEPU-1. Mol Cell Neurosci 2001;17:746-760. (Pubitemid 32430049)
48. Arai M, Itokawa M, Yamada K, et al. Association of neural cell adhesion molecule 1 gene polymorphisms with bipolar affective disorder in Japanese individuals. Biol Psychiatry 2004;55:804-810. (Pubitemid 38429871)
49. Kurada P, White K. Epidermal growth factor receptor: its role in Drosophila eye differentiation and cell survival. Apoptosis 1999;4:239-243. (Pubitemid 29424761)
50. Lafuste P, Sonnet C, Chazaud B, et al. ADAM12 and alpha9beta1 integrin are instrumental in human myogenic cell differentiation. Mol Biol Cell 2005;16: 861-870. (Pubitemid 40165577)
51. Boire A, Covic L, Agarwal A, et al. PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells. Cell 2005;120: 303-313. (Pubitemid 40222426)
52. Shao R, Bao S, Bai X, et al. Acquired expression of periostin by human breast cancers promotes tumor angiogenesis through up-regulation of vascular endothelial growth factor receptor 2 expression. Mol Cell Biol 2004;24:3992-4003. (Pubitemid 38496176)
53. Tsukahara S, Ikeda R, Goto S, et al. Tumour necrosis factor alpha-stimulated gene-6 inhibits osteoblastic differentiation of human mesenchymal stem cells induced by osteogenic differentiation medium and BMP-2. Biochem J 2006;398:595-603. (Pubitemid 44453405)
54. Kos J, Sekirnik A, Premzl A, et al. Carboxypeptidases cathepsins X and B display distinct protein profile in human cells and tissues. Exp Cell Res 2005;306: 103-113. (Pubitemid 40692776)
55. Aertgeerts K, Levin I, Shi L, et al. Structural and kinetic analysis of the substrate specificity of human fibroblast activation protein alpha. J Biol Chem 2005; 280:19441-19444. (Pubitemid 41379462)
56. Schacht V, Dadras SS, Johnson LA, et al. Up-regulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors. Am J Pathol 2005; 166:913-921. (Pubitemid 40315647)
57. Masuda N, Ohnishi T, Kawamoto S, et al. Analysis of chemical modification of RNA from formalin-fixed samples and optimization of molecular biology applications for such samples. Nucleic Acids Res 1999; 27:4436-4443. (Pubitemid 29533185)
58. Penland SK, Keku TO, Torrice C, et al. RNA expression analysis of formalin-fixed paraffin-embedded tumors. Lab Invest 2007;87:383-391. (Pubitemid 46474570)
59. Karsten SL, Van Deerlin VM, Sabatti C, et al. An evaluation of tyramide signal amplification and archived fixed and frozen tissue in microarray gene expression analysis. Nucleic Acids Res 2002;30:E4.
60. Benchekroun M, DeGraw J, Gao J, et al. Impact of fixative on recovery of mRNA from paraffin-embedded tissue. Diagn Mol Pathol 2004;13:116-125. (Pubitemid 38668147)
61. Hoheisel JD. Microarray technology: beyond transcript profiling and genotype analysis. Nat Rev Genet 2006; 7:200-210. (Pubitemid 43361531)
62. Sotiriou C, Piccart MJ. Taking gene-expression profiling to the clinic: when will molecular signatures become relevant to patient care? Nat Rev Cancer 2007;7:545-553. (Pubitemid 46985399)
63. Brazma A, Vilo J. Gene expression data analysis. Microbes Infect 2001;3:823-829. (Pubitemid 32913165)
64. Frueh FW. Impact of microarray data quality on genomic data submissions to the FDA. Nat Biotechnol 2006;24:1105-1107. (Pubitemid 44359720)
65. Farragher SM, Tanney A, Kennedy RD, et al. RNA expression analysis from formalin fixed paraffin embedded tissues. Histochem Cell Biol 2008;130: 435-445.
66. Kunz M, Ibrahim SM, Koczan D, et al. DNA microarray technology and its applications in dermatology. Exp Dermatol 2004;13:593-606. (Pubitemid 39345268)
67. Hey Y, Pepper SD. Interesting times for microarray expression profiling. Brief Funct Genomic Proteomic 2009;8:170-173.
68. Loudig O, Milova E, Brandwein-Gensler M, et al. Molecular restoration of archived transcriptional profiles by complementary-template reverse- transcription (CT-RT). Nucleic Acids Res 2007;35:e94.
69. Xiang CC, Chen M, Ma L, et al. A new strategy to amplify degraded RNA from small tissue samples for microarray studies. Nucleic Acids Res 2003;31:e53.
70. Xiang Z, Yang Y, Ma X, et al. Microarray expression profiling: analysis and applications. Curr Opin Drug Discov Devel 2003;6:384-395. (Pubitemid 36705508)
71. Chen J, Byrne Jr GE, Lossos IS. Optimization of RNA extraction from formalin-fixed, paraffin-embedded lymphoid tissues. Diagn Mol Pathol 2007;16:61-72. (Pubitemid 47164737)
72. Bibikova M, Yeakley JM, Chudin E, et al. Gene expression profiles in formalin-fixed, paraffin-embedded tissues obtained with a novel assay for microarray analysis. Clin Chem 2004;50:2384-2386. (Pubitemid 39552178)
73. Bibikova M, Yeakley JM, Wang-Rodriguez J, et al. Quantitative expression profiling of RNA from formalin-fixed, paraffin-embedded tissues using randomly assembled bead arrays. Methods Mol Biol 2008;439:159-177.
74. Lee J, Hever A, Willhite D, et al. Effects of RNA degradation on gene expression analysis of human postmortem tissues. Faseb J 2005;19:1356-1358. (Pubitemid 41113748)
75. Frank M, Doring C, Metzler D, et al. Global gene expression profiling of formalin-fixed paraffin-embedded tumor samples: a comparison to snap-frozen material using oligonucleotide microarrays. Virchows Arch 2007;450:699-711. (Pubitemid 46986227)
76. Coudry RA, Meireles SI, Stoyanova R, et al. Successful application of microarray technology to microdis-sected formalin-fixed, paraffin-embedded tissue. J Mol Diagn 2007;9:70-79. (Pubitemid 47322016)
77. Scicchitano MS, Dalmas DA, Bertiaux MA, et al. Preliminary comparison of quantity, quality, and micro-array performance of RNA extracted from formalin-fixed, paraffin-embedded, and unfixed frozen tissue samples. J Histochem Cytochem 2006;54:1229-1237. (Pubitemid 44623343)
78. Lassmann S, Kreutz C, Schoepflin A, et al. A novel approach for reliable microarray analysis of micro-dissected tumor cells from formalin-fixed and paraffin-embedded colorectal cancer resection specimens. J Mol Med 2009;87:211-224.
79. Chung CH, Parker JS, Ely K, et al. Gene expression profiles identify epithelial-to-mesenchymal transition and activation of nuclear factor-kappaB signaling as characteristics of a high-risk head and neck squamous cell carcinoma. Cancer Res 2006;66: 8210-8218. (Pubitemid 44299189)
80. Haque T, Faury D, Albrecht S, et al. Gene expression profiling from formalin-fixed paraffin-embedded tumors of pediatric glioblastoma. Clin Cancer Res 2007;13:6284-6292. (Pubitemid 350075016)
81. Onken MD, Worley LA, Ehlers JP, et al. Gene expression profiling in uveal melanoma reveals two molecular classes and predicts metastatic death. Cancer Res 2004;64:7205-7209. (Pubitemid 39372052)
82. Rogerson L, Darby S, Jabbar T, et al. Application of transcript profiling in formalin-fixed paraffin-embedded diagnostic prostate cancer needle biopsies. BJU Int 2008;102:364-370. (Pubitemid 352019196)
83. Van Deerlin VM, Gill LH, Nelson PT. Optimizing gene expression analysis in archival brain tissue. Neuro-chem Res 2002;27:993-1003. (Pubitemid 35316098)
84. Compton CC (ed). Introductory session. Proceedings of the 3rd Annual Biospecimen Research Network Symposium, 24-25 March, United States and Canadian Academy of Pathology 99th Annual Meeting, Washington, DC, 2010.
85. Kaddu S, Leinweber B. Podoplanin expression in fibrous histiocytomas and cellular neurothekeomas. Am J Dermatopathol 2009;31:137-139.
86. Fullen DR, Reed JA, Finnerty B, et al. S100A6 expression in fibrohistiocytic lesions. J Cutan Pathol 2001;28:229-234. (Pubitemid 32391822)
87. Enzinger FM, Zhang RY. Plexiform fibrohistiocytic tumor presenting in children and young adults. An analysis of 65 cases. Am J Surg Pathol 1988;12: 818-826.
88. Remstein ED, Arndt CA, Nascimento AG. Plexiform fibrohistiocytic tumor: clinicopathologic analysis of 22 cases. Am J Surg Pathol 1999;23:662-670. (Pubitemid 29262829)
89. Jaffer S, Ambrosini-Spaltro A, Mancini AM, et al. Neurothekeoma and plexiform fibrohistiocytic tumor: mere histologic resemblance or histogenetic relationship? Am J Surg Pathol 2009;33:905-913.
90. Moosavi C, Jha P, Fanburg-Smith JC. An update on plexiform fibrohistiocytic tumor and addition of 66 new cases from the Armed Forces Institute of Pathology, in honor of Franz M Enzinger, MD. Ann Diagn Pathol 2007;11:313-319. (Pubitemid 47380437)